UWMC Bears Dig In as Q2 Print Arrives
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
UWM Holdings reports Q2 results today with the stock at $1.84 — down another 5.6% on Wednesday — and the setup materially unchanged from yesterday's article: nearly 30% of the float sold short, options more defensive than at any point in the past year, and analysts pointing to a stock worth roughly twice the current price.
The options market is the freshest signal heading into the print. The put/call ratio jumped to 0.33 yesterday, more than two standard deviations above its 20-day average of 0.25 and the most defensive reading recorded over the past 52 weeks outside of one outlier spike. That shift has arrived in just the last three sessions — the PCR was running below 0.23 through most of July — suggesting traders moved quickly to hedge once the earnings date came into focus. The short position itself has barely budged: 29.7% of the free float is sold short, essentially flat on the week but up 31% over the past month. Availability remains at 61%, tighter than the 90%-plus levels that prevailed through most of July but not so constrained that new shorts face meaningful friction. Borrowing costs have edged up about 5% on the week to 1.54%, still modest in absolute terms.
The analyst community has been cutting targets steadily, even as ratings lean cautiously constructive. Morgan Stanley trimmed its target from $5.00 to $3.00 in late July while holding a neutral stance — a signal that even the sidelined view is coming down to earth. Barclays, still carrying an Overweight, cut its target to $4.00. The mean target across the coverage group now sits near $3.87, roughly 110% above the current price. That gap is the heart of the bull case: at 4.1x the 2027 earnings estimate and with $1.6 billion in tangible equity, bears may be getting paid well for a risk that is already widely understood. The bear case rests on the dividend — last paid in 2022, the prospect of a formal cut would remove one remaining pillar of support — alongside leverage concerns and the cash-flow drag from capitalising the MSR portfolio. The COO and Chief Strategy Officer both sold shares in May, and the CEO sold over $14 million worth across four consecutive days around the same period, a cluster that has not been offset by any subsequent buying.
The Q2 print is therefore less a referendum on whether UWM is under pressure — the market has priced in considerable pain at $1.84 — and more a test of whether origination volumes and margin can justify holding a dividend and balance sheet that analysts increasingly flag as unsustainable.
Stocks in this article
See the live data behind this article on ORTEX.
Open UWMC on ORTEX →How this article was generated
- Generated
- 6 Aug 2026, 04:47
- Data as of
- 6 Aug 2026, 04:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
- Validation notes
- soft: missing section mentions: short interest (informational only)
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.